UCLA performed most heart and lung transplants in the United States in 2016

Amanda GriswoldUCLA heart and lung transplants teams. UCLA performed the highest combined number of heart and lung transplants among all U.S. medical centers in 2016, according to United Network for Organ Sharing data, a nonprofit that manages the nation ’s organ transplant system.UCLA ’s thoracic transplant program performed 170 transplants during the 12-month period: 103 adult lung transplants, 58 adult heart transplants and nine pediatric heart transplants, according to UNOS.“This accomplishment is a tribute to our dedicated surgeons, physicians, nurses and allied health care professionals who are open to new challenges,” said Dr. Abbas Ardehali, the program’s surgical director. “We take pride in the innovative nature of our program and look forward to setting n ew standards in the years to come.”The UCLA program ranks among the country ’s best in terms of patient survival rates and outcomes of the transplanted organ, according to the Scientific Registry of Transplant Recipients. UCLA began performing heart transplants in 1985 and lung transplants in 1988. Thetransplant program has become a world leader and has pioneered numerous advances in transplant research, surgical technique, organ procurement and patient care.  
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

African Americans (AA) have reduced survival compared to Caucasians after heart transplantation (HTx).
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research
The purpose of this study is to evaluate the utility of vasoactive-inotropic score (VIS) in predicting outcomes after left ventricular assist device (LVAD) implantation and explore possible mechanisms of post-operative hemodynamic instability.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
In this study we describe 2 cases of successful adult DCD HT performed at our institution using an original protocol.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Featured papers Source Type: research
The continuous-flow centrifugal HeartMate 3 left ventricular assist device (Abbott, Abbott Park, IL) is associated with a low risk of de-novo pump thrombosis. In a previous study (the Minimal AnticoaGulation EvaluatioN To aUgment heMocompatibility [MAGENTUM-1] study, ClinicalTrials.gov No. NCT03078374; funded by Abbott and the Ministry of Health, Czech Republic), we reported results of a prospective, observational, pilot trial of reduced intensity warfarin (target international normalized ratio [INR] range 1.5 –1.9) with aspirin in 15 patients implanted with a HeartMate 3 pump and enrolled after 6 weeks.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: RESEARCH CORRESPONDENCE Source Type: research
Conditions:   Acute Leukemia;   CML;   Myelodysplasia;   Lymphoma Interventions:   Procedure: Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate;   Drug: Tacrolimus;   Drug: Methotrexate;   Procedure: Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Mycophenolate Mofetil/Post-Transplant Cyclophosphamide;   Drug: Mycophenolate Mofetil;   Drug: Cyclophosphamide Sponsors:   Medical College of Wisconsin;   National Heart, Lung, and Blood Institute (NHLBI);   ...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Abstract PURPOSE OF REVIEW: Owing to long waitlist times and high waitlist morbidity and mortality, strategies to increase utilization of hepatitis C viremic-deceased donor organs are under investigation in kidney, liver, heart, and lung transplantation. RECENT FINDINGS: Direct-acting antiviral medications for hepatitis C virus infection have high cure rates and are well tolerated. Small, single-center trials in kidney and heart transplant recipients have demonstrated that with early posttransplant direct-acting antiviral therapy, 100% of uninfected recipients of hepatitis C viremic organs have been cured of ...
Source: Current Opinion in Organ Transplantation - Category: Transplant Surgery Authors: Tags: Curr Opin Organ Transplant Source Type: research
Purpose of review Owing to long waitlist times and high waitlist morbidity and mortality, strategies to increase utilization of hepatitis C viremic-deceased donor organs are under investigation in kidney, liver, heart, and lung transplantation. Recent findings Direct-acting antiviral medications for hepatitis C virus infection have high cure rates and are well tolerated. Small, single-center trials in kidney and heart transplant recipients have demonstrated that with early posttransplant direct-acting antiviral therapy, 100% of uninfected recipients of hepatitis C viremic organs have been cured of infection after tran...
Source: Current Opinion in Organ Transplantation - Category: Surgery Tags: ETHICAL CONSIDERATIONS OF ALLOCATION: Edited by David A. Axelrod Source Type: research
More News: Cardiology | Cardiovascular & Thoracic Surgery | Health Management | Heart | Heart Transplant | Lung Transplant | Nurses | Nursing | Pediatrics | Transplant Surgery | Transplants